690 related articles for article (PubMed ID: 23313277)
1. Salivary cortisol levels and the 2-year course of depressive and anxiety disorders.
Vreeburg SA; Hoogendijk WJ; DeRijk RH; van Dyck R; Smit JH; Zitman FG; Penninx BW
Psychoneuroendocrinology; 2013 Sep; 38(9):1494-502. PubMed ID: 23313277
[TBL] [Abstract][Full Text] [Related]
2. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
[TBL] [Abstract][Full Text] [Related]
3. Salivary cortisol levels in persons with and without different anxiety disorders.
Vreeburg SA; Zitman FG; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Hoogendijk WJ; Smit JH; Penninx BW
Psychosom Med; 2010 May; 72(4):340-7. PubMed ID: 20190128
[TBL] [Abstract][Full Text] [Related]
4. Parental history of depression or anxiety and the cortisol awakening response.
Vreeburg SA; Hartman CA; Hoogendijk WJ; van Dyck R; Zitman FG; Ormel J; Penninx BW
Br J Psychiatry; 2010 Sep; 197(3):180-5. PubMed ID: 20807961
[TBL] [Abstract][Full Text] [Related]
5. Increased cortisol awakening response was associated with time to recurrence of major depressive disorder.
Hardeveld F; Spijker J; Vreeburg SA; Graaf RD; Hendriks SM; Licht CM; Nolen WA; Penninx BW; Beekman AT
Psychoneuroendocrinology; 2014 Dec; 50():62-71. PubMed ID: 25179322
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant use and salivary cortisol in depressive and anxiety disorders.
Manthey L; Leeds C; Giltay EJ; van Veen T; Vreeburg SA; Penninx BW; Zitman FG
Eur Neuropsychopharmacol; 2011 Sep; 21(9):691-9. PubMed ID: 21458959
[TBL] [Abstract][Full Text] [Related]
7. Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers.
Vogel SWN; Bijlenga D; Verduijn J; Bron TI; Beekman ATF; Kooij JJS; Penninx BWJH
Psychoneuroendocrinology; 2017 May; 79():31-39. PubMed ID: 28249186
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-adrenal axis activity in older persons with and without a depressive disorder.
Rhebergen D; Korten NC; Penninx BW; Stek ML; van der Mast RC; Oude Voshaar R; Comijs HC
Psychoneuroendocrinology; 2015 Jan; 51():341-50. PubMed ID: 25462906
[TBL] [Abstract][Full Text] [Related]
9. The relationships of working conditions, recent stressors and childhood trauma with salivary cortisol levels.
Holleman M; Vreeburg SA; Dekker JJ; Penninx BW
Psychoneuroendocrinology; 2012 Jun; 37(6):801-9. PubMed ID: 22000684
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of cortisol levels on 2-year course of depression in older persons.
Kabia FM; Rhebergen D; van Exel E; Stek ML; Comijs HC
Psychoneuroendocrinology; 2016 Jan; 63():320-6. PubMed ID: 26546785
[TBL] [Abstract][Full Text] [Related]
11. Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders.
Veen G; Giltay EJ; DeRijk RH; van Vliet IM; van Pelt J; Zitman FG
Metabolism; 2009 Jun; 58(6):821-7. PubMed ID: 19375126
[TBL] [Abstract][Full Text] [Related]
12. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
Stewart JW; Quitkin FM; McGrath PJ; Klein DF
J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
[TBL] [Abstract][Full Text] [Related]
13. Reduced hypothalamic-pituitary-adrenal axis activity in chronic multi-site musculoskeletal pain: partly masked by depressive and anxiety disorders.
Generaal E; Vogelzangs N; Macfarlane GJ; Geenen R; Smit JH; Penninx BW; Dekker J
BMC Musculoskelet Disord; 2014 Jul; 15():227. PubMed ID: 25007969
[TBL] [Abstract][Full Text] [Related]
14. Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis.
Wardenaar KJ; Vreeburg SA; van Veen T; Giltay EJ; Veen G; Penninx BW; Zitman FG
Biol Psychiatry; 2011 Feb; 69(4):366-73. PubMed ID: 21030010
[TBL] [Abstract][Full Text] [Related]
15. Prospective associations between the cortisol awakening response and first onsets of anxiety disorders over a six-year follow-up--2013 Curt Richter Award Winner.
Adam EK; Vrshek-Schallhorn S; Kendall AD; Mineka S; Zinbarg RE; Craske MG
Psychoneuroendocrinology; 2014 Jun; 44():47-59. PubMed ID: 24767619
[TBL] [Abstract][Full Text] [Related]
16. Altered psychobiological responsiveness in women with irritable bowel syndrome.
Suárez-Hitz KA; Otto B; Bidlingmaier M; Schwizer W; Fried M; Ehlert U
Psychosom Med; 2012; 74(2):221-31. PubMed ID: 22286854
[TBL] [Abstract][Full Text] [Related]
17. Are flatter diurnal cortisol rhythms associated with major depression and anxiety disorders in late adolescence? The role of life stress and daily negative emotion.
Doane LD; Mineka S; Zinbarg RE; Craske M; Griffith JW; Adam EK
Dev Psychopathol; 2013 Aug; 25(3):629-42. PubMed ID: 23880381
[TBL] [Abstract][Full Text] [Related]
18. Co-occurring manic symptomatology influences HPA axis alterations in depression.
Jabben N; Nolen WA; Smit JH; Vreeburg SA; Beekman AT; Penninx BW
J Psychiatr Res; 2011 Sep; 45(9):1208-13. PubMed ID: 21450306
[TBL] [Abstract][Full Text] [Related]
19. Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system.
Boschloo L; Vogelzangs N; Licht CM; Vreeburg SA; Smit JH; van den Brink W; Veltman DJ; de Geus EJ; Beekman AT; Penninx BW
Drug Alcohol Depend; 2011 Jul; 116(1-3):170-6. PubMed ID: 21330066
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenal axis activity in the comorbidity between obsessive-compulsive disorder and major depression.
Labad J; Soria V; Salvat-Pujol N; Segalàs C; Real E; Urretavizcaya M; de Arriba-Arnau A; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Alonso P; Menchón JM
Psychoneuroendocrinology; 2018 Jul; 93():20-28. PubMed ID: 29684711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
